|
Cleveland, OH, December 13, 2011 - Don Brown, CEO of Arteriocyte Cellular Therapies
Medical Systems (Arteriocyte) and Terri Sandu, Executive Director of Hard Hatted Women(HHW), are combining efforts to raise awareness of opportunities for women in Science, Technology, Engineering and Math (STEM) disciplines. They will inspire, celebrate and encourage women to choose careers and obtain the requisite education and training to thrive in
STEM fields at a breakfast to be held tomorrow. read more ...
Cleveland, OH, July 20, 2011 - Arteriocyte receives $1 Million award from Ohio Third Frontier Program to advance its NANEX™ technology toward clinical use. read more ...
Cleveland, OH, June 7, 2011 - Arteriocyte and the US Army Institute of Surgical Research (USAISR) sign a CRADA to speed development of Cellular Therapies for Orthopaedic Trauma. read more ...
Cleveland, OH, January 28, 2011 - Arteriocyte announced today approval from the Food and Drug Administration (FDA) to initiate a Phase I clinical trial using its Magellan MAR01 technology in the treatment of Critical Limb
Ischemia (CLI). read more ...
Cleveland, OH, December 2, 2010 - Arteriocyte announces today the launch of its first commercially available Stem Cell Expansion System NANEX™ for research use. read more ...
Cleveland, OH, June 28, 2010 - Arteriocyte, Inc., was honored Friday by the Ohio Venture Association as a Venture of Year Award Finalist. read more ...
Cleveland, OH, April 30, 2009 - Arteriocyte announced today a $4.99 Million award from the Ohio Third Frontier Commission's Research Commercialization Program. read more ...
Monday, November 10, 2008 - Arteriocyte announced today a $1,950,000 award from DARPA for the company's Nanofiber Based System (NANEX) technology for the Production of Red
Blood Cells project. read more ...
Monday, September 22, 2008 - NIH Fast Track Grant Awarded to Arteriocyte for Critical Limb Ischemia Research. read more ...
Tuesday, May 27, 2008 - Congresswoman Stephanie Tubbs Jones (OH-11) will tour the laboratory facilities of Arteriocyte, Inc.,a clinical stage biotechnology company concentrating on adult stem cell therapies. read more ...
Tuesday, January 15, 2008 - Arteriocyte Receives $509,000 Grant from Cleveland Clinic’s Global Cardiovascular Innovation Center. read more ...
Thursday, November 29, 2007 - Arteriocyte awarded $800,000 for Cellular Therapy for Battlefield Wounds project. read more ...
Thursday, November 08, 2007 - Arteriocyte Medical Systems Forms Strategic Partnership with Medtronic including Acquisition of the Magellan Platelet Rich Plasma Business. read more ...
Thursday, October 25, 2007 - Arteriocyte, Inc. and DW Healthcare Partners, today announced the formation of Arteriocyte Medical Systems, Inc., launching the company with a $10 million growth capital investment. read more ...
Thursday, October 04, 2007 - National Eye Institute (NIH) Awards $310,000 Grant to Arteriocyte and Cleveland Clinic for Eye Disease Research. read more ...
Monday, October 16, 2006 - Arteriocyte Inc. Completes Phase I Stem Cell Clinical Trial Enrollment. read more ...
Friday, May 19, 2006 - Arteriocyte, Inc. Receives State Research Support. read more ...
Thursday, January 19, 2006 - Phase I Clinical Trial Initiation and $1.4 Million NIH STTR Grant. read more ...
Monday, November 14, 2005 - Feds Give Researchers OK for Safety Test of Adult Stem Cells in Patients with Heart Disease. read more ...
Wednesday, May 11, 2005 - NIH Awards Funding to Case Biotech Firm for Heart Disease. read more ...
Monday, June 14, 2004 - Case Spins Out Arteriocyte, First Stem Cell Company. read more ...
Tuesday, May 18, 2004 - Case Business Launch Competition Winners Announced. read more ...
|
